Drug Side Effects
Search
MAST CELL DEGRANULATION PRESENT
MAST CELL DEGRANULATION PRESENT
was reported 19 times
MAST CELL DEGRANULATION PRESENT is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
alpha-Glucosidase Inhibitor [EPC]
7
0.0014
1
Calcitonin Gene-related Peptide Receptor Antagonist [EPC]
1
0.0001
2
Central alpha-2 Adrenergic Agonist [EPC]
7
0.0001
3
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]
1
0.0001
4
Glycopeptide Antibacterial [EPC]
4
0.0001
5
P2Y12 Platelet Inhibitor [EPC]
7
0.0001
6
Nitrate Vasodilator [EPC]
5
0.0001
7
Angiotensin Converting Enzyme Inhibitor [EPC]
7
0.0001
8
Provitamin D2 Compound [EPC]
1
0.0000
9
HMG-CoA Reductase Inhibitor [EPC]
7
0.0000
10
Histamine-2 Receptor Antagonist [EPC]
2
0.0000
11
Proton Pump Inhibitor [EPC]
8
0.0000
12
Catecholamine [EPC]
1
0.0000
13
Histamine-1 Receptor Antagonist [EPC]
1
0.0000
14
Anti-IgE [EPC]
1
0.0000
15
Opioid Agonist [EPC]
2
0.0000
16
Kinase Inhibitor [EPC]
4
0.0000
17
Janus Kinase Inhibitor [EPC]
1
0.0000
18
Expectorant [EPC]
1
0.0000
19
Vitamin C [EPC]
1
0.0000
20
GLP-1 Receptor Agonist [EPC]
1
0.0000
21
Interleukin-4 Receptor alpha Antagonist [EPC]
1
0.0000
22
Corticosteroid [EPC]
1
0.0000
23
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000